A SUBSET OF PATIENTS WITH RECURRENT SPONTANEOUS-ABORTION IS DEFICIENT IN TRANSFORMING GROWTH-FACTOR BETA-2-PRODUCING SUPPRESSOR CELLS IN UTERINE TISSUE NEAR THE PLACENTAL ATTACHMENT SITE

被引:84
作者
LEA, RG
UNDERWOOD, J
FLANDERS, KC
HIRTE, H
BANWATT, D
FINOTTO, S
OHNO, I
DAYA, S
HARLEY, C
MICHEL, M
MOWBRAY, JF
CLARK, DA
机构
[1] MCMASTER UNIV, DEPT MED, HAMILTON, ON L8N 3Z5, CANADA
[2] MCMASTER UNIV, DEPT PATHOL, HAMILTON, ON L8N 3Z5, CANADA
[3] MCMASTER UNIV, MOLEC IMMUNOL VIROL PROGRAM, HAMILTON, ON L8N 3Z5, CANADA
[4] MCMASTER UNIV, DEPT OBSTET & GYNECOL, HAMILTON, ON L8N 3Z5, CANADA
[5] MCMASTER UNIV, DEPT BIOCHEM, HAMILTON, ON L8N 3Z5, CANADA
[6] ST MARKS HOSP, SCH MED, DEPT IMMUNOPATHOL, LONDON EC1V 2PS, ENGLAND
[7] NCI, CHEMOPREVENT LAB, BETHESDA, MD 20892 USA
关键词
RECURRENT ABORTION; DECIDUA; SUPPRESSOR CELLS; TRANSFORMING GROWTH FACTOR BETA;
D O I
10.1111/j.1600-0897.1995.tb00919.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
PROBLEM: To determine if patients with unexplained recurrent miscarriage have a deficiency of decidual immunosuppressor cells that produce transforming growth factor beta type 2, as has been found in mice with abortion due to rejection and/or trophoblast failure. METHODS: Decidual biopsy specimens were taken as near to the placental attachment site as possible under ultrasound guidance from first trimester legal termination (control) patients with recurrent miscarriage and non-viable pregnancy, and from patients with sporadic missed abortion. The tissue was tested for TGF beta-2(+) suppressor cells by in situ hybridization, immunohistochemistry, and analysis of supernatants. RESULTS: TGF beta 2-related suppressor molecules similar but not identical to those identified in pregnant mice were released by decidual lymphoid cells. Fifty percent of 14 recurrent miscarriage patients showed a lack of suppressor cells and 59% were subnormal in comparison to 20 controls and 5 sporadic miscarriage patients, where 80-85% of the patients had detectable suppressor cells. CONCLUSIONS: Suppressor cell deficiency is compatible with a role for rejection and/or trophoblast failure in some patients with recurrent miscarriage. Presence of suppressor cells in most patients with missed abortion (4/5) is compatible with an alternative cause of fetal death, similar to findings reported in genetic fetal death mice.
引用
收藏
页码:52 / 64
页数:13
相关论文
共 39 条
[1]   A TRANSFORMING GROWTH-FACTOR-BETA-2 (TGF-BETA-2)-LIKE IMMUNOSUPPRESSIVE FACTOR IN AMNIOTIC-FLUID AND LOCALIZATION OF TGF-BETA-2 MESSENGER-RNA IN THE PREGNANT UTERUS [J].
ALTMAN, DJ ;
SCHNEIDER, SL ;
THOMPSON, DA ;
CHENG, HL ;
TOMASI, TB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (05) :1391-1401
[2]  
BELL SC, 1988, J REPROD FERTIL S, V36, P106
[3]  
BOLTON AE, 1987, LANCET, V1, P593
[4]   RETROSPECTIVE AND PROSPECTIVE EPIDEMIOLOGICAL-STUDIES OF 1500 KARYOTYPED SPONTANEOUS HUMAN ABORTIONS [J].
BOUE, J ;
BOUE, A ;
LAZAR, P .
TERATOLOGY, 1975, 12 (01) :11-26
[5]   LOW MATERNAL SERUM LEVELS OF PREGNANCY ASSOCIATED PLASMA PROTEIN-A (PAPP-A) IN THE 1ST TRIMESTER IN ASSOCIATION WITH ABNORMAL FETAL KARYOTYPE [J].
BRAMBATI, B ;
MACINTOSH, MCM ;
TEISNER, B ;
MAGUINESS, S ;
SHRIMANKER, K ;
LANZANI, A ;
BONACCHI, I ;
TULUI, L ;
CHARD, T ;
GRUDZINSKAS, JG .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1993, 100 (04) :324-326
[6]   TRANSFORMING GROWTH-FACTOR-BETA-2 PREVENTS PRETERM DELIVERY INDUCED BY INTERLEUKIN-1-ALPHA AND TUMOR-NECROSIS-FACTOR-ALPHA IN THE RABBIT [J].
BRY, K ;
HALLMAN, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (04) :1318-1322
[7]   TGF-BETA-2 GENE AND PROTEIN EXPRESSION IN MATERNAL AND FETAL TISSUES AT VARIOUS STAGES OF MURINE DEVELOPMENT [J].
CHENG, HL ;
SCHNEIDER, SL ;
KANE, CM ;
GOLLNICK, SO ;
GRANDE, C ;
THOMPSON, D ;
PIETRZAK, E ;
TOMASI, TB .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1993, 25 (02) :133-148
[8]   DECIDUA-ASSOCIATED SUPPRESSOR ACTIVITY AND VIABILITY OF INDIVIDUAL IMPLANTATION SITES OF ALLOPREGNANT C3H MICE [J].
CLARK, DA ;
DRAKE, B ;
HEAD, JR ;
STEDRONSKACLARK, J ;
BANWATT, D .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1990, 17 (03) :253-264
[9]  
CLARK DA, 1991, CRIT REV IMMUNOL, V11, P215
[10]  
CLARK DA, 1990, J IMMUNOL, V144, P3008